US scientists have claimed that a malaria drug can increase the survival rate of patients with severe Covid-19 by as much as 200 per cent. Doctors found that when ventilated patients were given hydroxychloroquine with zinc, their condition improved rapidly.
The study was conducted by Saint Barnabas Medical Center in New Jersey. 255 patients were involved. The results were published two weeks ago here: https://www.medrxiv.org/content/10.1101/2021.05.28.21258012v1.article-info
Friends and supporters of former US President Donald trump were quick to jump on the findings. Trump was a strong advocate for treating severe Covid-19 with hydroxychloroquine. 
Trump was widely criticised for pushing the drug. Scientists labelled him reckless. His adviser Dr. Anthony Fauci said at the time, that all the evidence to hand suggested that the treatment was ineffective against covid.
In March this year, the World Health Organization warned against using the drug to treat coronavirus. The WHO produced data which alleged hydroxychloroquine was ineffective.
Yet the authors of the new report claim:
“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients.”
Last December, a study published by the International Journal of Antimicrobial Agents showed 84 per cent fewer hospitalizations among patients treated with the drug.
In January this year, a study carried out by Hackensack Meridian Health, showed encouraging results in patients with mild covid symptoms who were given hydroxychloroquine.
As I write this, UK Health Secretary Matt Hancock is facing a committee in Westminster. He’s answering questions about his government’s handling of the pandemic. It’s a walk in the park for Hancock. It’s one softball question after another so far.
Don’t hold your breath waiting for a committee member to ask him if he’d considered sending hydroxychloroquine or ivermectin to care homes and hospitals, to treat those who had to be ventilated for severe covid.
